Interplay between scatter factor receptors and B plexins controls invasive growth

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Oncogene

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1207650PMID 15184888
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Met-HGF/SF: tumorigenesis, invasion and metastasis.

  2007cited by this paper
• Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus

  2003cited by this paper
• The MSP Receptor Regulates α6β4 and α3β1 Integrins via 14-3-3 Proteins in Keratinocyte Migration

  2003cited by this paper
• The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration.

  2003cited by this paper
• Functional Regulation of Semaphorin Receptors by Proprotein Convertases*

  2003cited by this paper
• Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential

  2003cited by this paper
• Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

  2003cited by this paper
• The Semaphorin 4D receptor controls invasive growth by coupling with Met

  2002influential reference
• Dysregulation of Met receptor tyrosine kinase activity in invasive tumors.

  2002cited by this paper
• Scatter-factor and semaphorin receptors: cell signalling for invasive growth

  2002cited by this paper
• Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo

  2002cited by this paper
• Plexin B Regulates Rho through the Guanine Nucleotide Exchange Factors Leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF*

  2002cited by this paper
• CD44 is required for two consecutive steps in HGF/c-Met signaling.

  2002cited by this paper
• The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG

  2002cited by this paper
• Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology.

  2002cited by this paper
• A mechanism of cell survival: sequestration of Fas by the HGF receptor Met.

  2002cited by this paper
• A Signaling Adapter Function for 6 4 Integrin in the Control of HGF-Dependent Invasive Growth

  2001cited by this paper
• Plexin-B semaphorin receptors interact directly with active Rac and regulate the actin cytoskeleton by activating Rho.

  2001cited by this paper
• A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth.

  2001cited by this paper
• Cross-talk between the proto-oncogenes Met and Ron

  2000cited by this paper
• A novel germ line juxtamembrane Met mutation in human gastric cancer

  2000cited by this paper
• The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner.

  2000cited by this paper
• Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas

  2000cited by this paper
• Macrophage stimulating protein-induced epithelial cell adhesion is mediated by a PI3-K-dependent, but FAK-independent mechanism.

  1999cited by this paper
• Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.

  1999cited by this paper
• Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF.

  1998cited by this paper
• Plexin A is a neuronal semaphorin receptor that controls axon guidance.

  1998influential reference
• Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration.

  1998cited by this paper
• Overexpression of the RON gene in human breast carcinoma

  1998cited by this paper
• A point mutation in the MET oncogene abrogates metastasis without affecting transformation.

  1997cited by this paper
• Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

  1997cited by this paper
• A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor.

  1996cited by this paper
• The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein.

  1995cited by this paper
• A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.

  1994cited by this paper
• RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP.

  1994cited by this paper
• Identification of the ron gene product as the receptor for the human macrophage stimulating protein.

  1994cited by this paper
• Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

  1991influential reference
• Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

  1991cited by this paper
• Tyrosine kinase receptor indistinguishable from the c-met protein

  1989cited by this paper

• Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis

  2025cites this paper
• Functional Diversity of Two Novel Embryonic Microglial Subpopulations and Their Developmental Trajectories in Developing Mouse Brains

  2025cites this paper
• Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes

  2024cites this paper
• Plexin-B1 and Plexin-B2 play non-redundant roles in GABAergic synapse formation.

  2024cites this paper
• c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.

  2024cites this paper
• Semaphorin Receptors Antagonize Wnt Signaling Through Beta-Catenin Degradation

  2024cites this paper
• The MET Oncogene Network of Interacting Cell Surface Proteins

  2024cites this paper
• Plexin-B1 and Plexin-B2 play non-redundant roles in GABAergic synapse formation

  2023cites this paper
• Plexin-mediated neuronal development and neuroinflammatory responses in the nervous system.

  2023cites this paper
• MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-γ)-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells

  2023cites this paper
• Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis

  2023cites this paper
• Plexins as Regulators of Cancer Cell Proliferation, Migration, and Invasivity

  2023cites this paper
• The Role of cMET in Gastric Cancer—A Review of the Literature

  2023cites this paper
• The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer

  2022cites this paper
• Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis

  2022cites this paper
• The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies

  2022cites this paper
• MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1)

  2022cites this paper
• Receptor-driven invasion profiles in diffuse intrinsic pontine glioma

  2021cites this paper
• HGF/c-Met regulates p22phox subunit of the NADPH oxidase complex in primary mouse hepatocytes by transcriptional and post-translational mechanisms.

  2021cites this paper
• A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia

  2021cites this paper
• Plexins promote Hedgehog signaling through their cytoplasmic GAP activity

  2021cites this paper
• HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence

  2021cites this paper
• SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia

  2021cites this paper
• Proteomic Profiling of Small Extracellular Vesicles Secreted by Human Pancreatic Cancer Cells Implicated in Cellular Transformation

  2020cites this paper
• A comprehensive review of tumor proliferative and suppressive role of semaphorins and therapeutic approaches

  2020cites this paper
• c-Met as a potential therapeutic target in triple negative breast cancer

  2020cites this paper
• Targeting the Hepatocyte Growth Factor Receptor to Overcome Resistance to Targeted Therapies

  2019cites this paper
• The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies

  2019cites this paper
• HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers

  2019cites this paper
• Extracellular Targeting of Cell Signaling in Cancer: Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathways, First Edition. Edited by James W. Janetka and Roseann M. Benson

  2018cites this paper
• The Impact of the Epithelial–Mesenchymal Transition Regulator Hepatocyte Growth Factor Receptor/Met on Skin Immunity by Modulating Langerhans Cell Migration

  2018cites this paper
• The association of semaphorin 5A with lymph node metastasis and adverse prognosis in cervical cancer

  2018cites this paper
• The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis

  2018cites this paper
• Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer.

  2018cites this paper
• Transactivation of Met signalling by semaphorin4D in human placenta: implications for the pathogenesis of preeclampsia

  2018cites this paper
• The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

  2018cites this paper
• Discovery and Function of the HGF/MET and the MSP/RON Kinase Signaling Pathways in Cancer

  2018cites this paper
• Interferon-α-induced CD100 on naïve CD8+ T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction

  2017cites this paper
• Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma

  2017cites this paper
• Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis

  2017cites this paper
• Role of Plexin B1 in a Breast Cancer Cohort of Pakistani Patients and its Contribution Towards Cancer Metastasis as Indicated by an In Vitro Model.

  2017cites this paper
• Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges

  2017cites this paper
• Analysis of the interaction of Plexin-B1 and Plexin-B2 with Rnd family proteins

  2017cites this paper
• The Ron Receptor Tyrosine Kinase as a Mediator of Inflammation and Tumorigenesis

  2016cites this paper
• The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases

  2016cites this paper
• The semaphorins and their receptors as modulators of tumor progression.

  2016cites this paper
• Transmembrane semaphorins: Multimodal signaling cues in development and cancer

  2016cites this paper
• The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer

  2016cites this paper
• Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

  2016cites this paper
• Tumorigenesis and Neoplastic Progression Semaphorin 3 E Expression Correlates Inversely with Plexin D 1 During Tumor Progression

  2016cites this paper
• The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer

  2016cites this paper
• Molecular Signaling in Oral Cancer Invasion and Metastasis

  2016cites this paper
• Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?

  2016cites this paper
• The role of the semaphorins in cancer

  2016cites this paper
• Conséquences de l'hypoxie sur la régulation de la signalisation HGF/SF-MET

  2015cites this paper
• A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells

  2015cites this paper
• Plexin-B2 promotes invasive growth of malignant glioma

  2015cites this paper
• Evaluation of VX 15 / 2503 ; a Humanized IgG 4 Anti-SEMA 4 D Antibody

  2015cites this paper
• c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences

  2015influential citation
• cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance

  2015influential citation
• Identification of biomarkers for development of NF1-associated malignant peripheral nerve sheath tumours

  2015cites this paper
• Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody

  2015cites this paper
• The MET Receptor Family

  2015cites this paper
• Semaphorins

  2015cites this paper
• Shaping the Reproductive System: Role of Semaphorins in Gonadotropin-Releasing Hormone Development and Function

  2015cites this paper
• c-Met targeting in advanced gastric cancer: An open challenge.

  2015cites this paper
• Regulation of Angiogenesis and Tumor Progression by Semaphorins

  2015cites this paper
• Reduced expression of semaphorin 4D and plexin-B in breast cancer is associated with poorer prognosis and the potential linkage with oestrogen receptor.

  2015cites this paper
• Mechanisms of endothelial cell migration

  2014cites this paper
• Effets des clivages du récepteur tyrosine kinase Met par les calpaïnes sur la motilité et la mort cellulaire

  2014cites this paper
• Plexin-B1 Receptor Complex into the γ Recruitment of Phospholipase C Semaphorin 4D Signaling Requires the

  2014cites this paper
• Targeting the MET gene for the treatment of non-small-cell lung cancer.

  2014cites this paper
• MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside.

  2014cites this paper
• The Plexin-B family and its role in cancer progression.

  2014cites this paper
• Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression

  2014cites this paper
• Vitamin D3 Receptor Signaling in Mammary Gland Development and Ron-Mediated Breast Cancer

  2014cites this paper
• Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progress.

  2014cites this paper
• Physiological Signaling and Structure of the HGF Receptor MET

  2014cites this paper
• Semaphorins Biology and Their Significance in Cancer

  2014cites this paper
• Assay development for the discovery of semaphorin 3B inducing agents from natural product sources.

  2014cites this paper
• MET and ALK as targets for the treatment of NSCLC.

  2014cites this paper
• Experimental validation of 5 in-silico predicted glioma biomarkers.

  2013cites this paper
• Intron Retention in the Alternatively Spliced Region of RON Results from Weak 3’ Splice Site Recognition

  2013cites this paper
• Ki-67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively

  2013cites this paper
• Biological significance and targeting of c-Met tyrosine kinase receptor in cancer.

  2013cites this paper
• THROMBOSIS AND HEMOSTASIS Identi fi cation of a calmodulin-binding domain in Sema 4 D that regulates its exodomain shedding in platelets

  2013cites this paper
• Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets.

  2013cites this paper
• Function of mutant and wild-type plexinB1 in prostate cancer cells

  2013cites this paper
• Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure

  2013cites this paper
• Epithelial and Stromal Ron Receptor Expression Promotes Tumor Growth in a Murine Model of Prostate Cancer

  2013cites this paper
• Experimentalvalidationof5in-silicopredicted glioma biomarkers

  2013cites this paper
• Semaphorin Signaling in the Development and Function of the Gonadotropin Hormone-Releasing Hormone System

  2013cites this paper
• Semaphorins in the development, homeostasis and disease of hormone systems.

  2013cites this paper
• Role of Met Axis in Head and Neck Cancer

  2013cites this paper
• The role of semaphorins and their receptors in vascular development and cancer.

  2013cites this paper
• Class 3 semaphorins: physiological vascular normalizing agents for anti‐cancer therapy

  2013cites this paper
• MET as a potential therapeutic target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors for therapeutic intervention

  2013cites this paper
• Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton

  2012cites this paper
• C-MET as a Novel Target for the Treatment of Renal Cell Carcinoma

  2012cites this paper
• Investigating c-Met Signaling in Non-Small Cell Lung Cancer

  2012cites this paper